| Proton pump inhibitor therapy and potential long-term harm VD Corleto, S Festa, E Di Giulio, B Annibale Current opinion in endocrinology, diabetes and obesity 21 (1), 3-8, 2014 | 158 | 2014 |
| Molecular pathology and genetics of pancreatic endocrine tumours. G Capurso, S Festa, R Valente, M Piciucchi, F Panzuto, RT Jensen, ... Journal of molecular endocrinology 49 (1), R37-50, 2012 | 111 | 2012 |
| Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study L Biancone, A Armuzzi, ML Scribano, F Castiglione, R D’incà, A Orlando, ... Inflammatory Bowel Diseases 26 (3), 450-459, 2020 | 64 | 2020 |
| Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives G Capurso, N Fazio, S Festa, F Panzuto, F De Braud, G Delle Fave Critical reviews in oncology/hematology 72 (2), 110-124, 2009 | 48 | 2009 |
| Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study D Pugliese, M Daperno, G Fiorino, E Savarino, E Mosso, L Biancone, ... Digestive and Liver Disease 51 (7), 972-977, 2019 | 40 | 2019 |
| Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence C Bezzio, S Festa, S Saibeni, C Papi Expert Review of Gastroenterology & Hepatology 11 (4), 339-347, 2017 | 34 | 2017 |
| Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study D Pugliese, G Privitera, F Crispino, N Mezzina, F Castiglione, G Fiorino, ... Alimentary pharmacology & therapeutics 56 (1), 95-109, 2022 | 33 | 2022 |
| Interstitial and granulomatous lung disease in inflammatory bowel disease patients E Eliadou, J Moleiro, DG Ribaldone, M Astegiano, K Rothfuss, ... Journal of Crohn's and Colitis 14 (4), 480-489, 2020 | 32 | 2020 |
| Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology FS Macaluso, A Orlando, C Papi, S Festa, D Pugliese, S Bonovas, ... Digestive and Liver Disease 54 (4), 440-451, 2022 | 31 | 2022 |
| Acute fulminant hepatitis E virus genotype 3e infection: description of the first case in Europe S Festa, AR Garbuglia, F Baccini, F Panzuto, MR Capobianchi, I Santino, ... Scandinavian Journal of Infectious Diseases 46 (10), 727-731, 2014 | 30 | 2014 |
| I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease L Peyrin-Biroulet, JF Rahier, J Kirchgesner, V Abitbol, S Shaji, A Armuzzi, ... Clinical Gastroenterology and Hepatology 21 (3), 771-788. e10, 2023 | 25 | 2023 |
| Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology FS Macaluso, C Papi, A Orlando, S Festa, D Pugliese, S Bonovas, ... Digestive and Liver Disease 55 (4), 442-453, 2023 | 24 | 2023 |
| Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study S Festa, ML Scribano, D Pugliese, C Bezzio, M Principi, DG Ribaldone, ... UEG Journal 9 (4), 507-516, 2021 | 24 | 2021 |
| Enteropathic spondyloarthritis: results from a large nationwide database analysis A Picchianti-Diamanti, R Lorenzetti, MS Chimenti, MM Luchetti, ... Autoimmunity Reviews 19 (2), 102457, 2020 | 23 | 2020 |
| Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review AE Ratajczak, S Festa, A Aratari, C Papi, A Dobrowolska, ... Frontiers in Nutrition 9, 1088693, 2023 | 19 | 2023 |
| Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care S Saibeni, L Scucchi, G Dragoni, C Bezzio, A Miranda, DG Ribaldone, ... United European Gastroenterology Journal 8 (10), 1228-1235, 2020 | 16 | 2020 |
| “Mucosal healing” in ulcerative colitis: Between clinical evidence and market suggestion C Pagnini, F Menasci, S Festa, G Rizzatti, G Delle Fave World Journal of Gastrointestinal Pathophysiology 5 (2), 54, 2014 | 14 | 2014 |
| Sustained clinical efficacy and mucosal healing of thiopurine maintenance treatment in ulcerative colitis: a real‐life study D Pugliese, A Aratari, S Festa, PM Ferraro, R Monterubbianesi, L Guidi, ... Gastroenterology Research and Practice 2018 (1), 4195968, 2018 | 13 | 2018 |
| Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study D Pugliese, G Privitera, F Rogai, A Variola, A Viola, L Laterza, ... UEG Journal 9 (1), 102-109, 2021 | 12 | 2021 |
| Critical review of the evidence on 5-aminosalicilate for chemoprevention of colorectal cancer in ulcerative colitis: a methodological question G Margagnoni, C Pagnini, F Menasci, S Festa, G Delle Fave Current Clinical Pharmacology 9 (1), 84-90, 2014 | 12 | 2014 |
